Pemazyre 4.5 mg tablets
PEARLDIFER
Phase 2 small_molecule active
Quick answer
Pemazyre 4.5 mg tablets for locally advanced intrahepatic cholangiocarcinoma (iCCA) with FGFR2 fusions/rearrangements is a Phase 2 program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The George Institute
- Indication
- locally advanced intrahepatic cholangiocarcinoma (iCCA) with FGFR2 fusions/rearrangements
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active